

This study examined health insurance records from January 1, 2012, through July 31, 2020, to better understand how hemoglobin levels are related to organ damage in people aged 12 years and older living with sickle cell disease. The study included more than 16,000 people aged 12 years and older who had at least 1 hemoglobin result. Researchers reviewed patients' records for 1 year after each test to see if any organ damage occurred.
Hemolysis, leading to hemolytic anemia (low hemoglobin), can damage the body over time—even when you don't feel it.


Researchers reviewed 2820 publications (January 1, 1998, to February 26, 2019) and included 41 studies that examined hemoglobin levels and clinical outcomes in people with sickle cell disease. Studies covered various sickle cell types and therapies. They compared average hemoglobin levels between people who had specific complications and people who did not have those complications, and reported on the difference.


Researchers reviewed 2820 publications (January 1, 1998, to February 26, 2019) and included 41 studies that examined hemoglobin levels and clinical outcomes in people with sickle cell disease. Studies covered various sickle cell types and therapies. Using data from these studies, they combined the findings in a model to estimate how outcomes might change when hemoglobin levels increased by 1 g/dL or more.
Organ damage is a leading cause of death in people with sickle cell disease. Working with your doctor to establish a regular monitoring plan may help catch problems early.